Miller Howard Investments Inc. NY Invests $573,000 in Cardinal Health, Inc. (NYSE:CAH)

Miller Howard Investments Inc. NY acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 4,847 shares of the company's stock, valued at approximately $573,000.

Several other large investors have also recently modified their holdings of the company. State Street Corp increased its stake in Cardinal Health by 4.6% during the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company's stock valued at $1,566,913,000 after purchasing an additional 627,253 shares in the last quarter. Geode Capital Management LLC increased its stake in Cardinal Health by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock valued at $633,298,000 after purchasing an additional 42,082 shares in the last quarter. Pacer Advisors Inc. increased its stake in Cardinal Health by 4.7% during the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company's stock valued at $474,203,000 after purchasing an additional 191,568 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Cardinal Health by 2.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company's stock valued at $162,976,000 after purchasing an additional 33,388 shares in the last quarter. Finally, Two Sigma Advisers LP increased its stake in Cardinal Health by 47.9% during the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock valued at $118,197,000 after purchasing an additional 346,362 shares in the last quarter. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Performance

NYSE CAH traded up $0.10 during mid-day trading on Thursday, reaching $127.16. 2,390,521 shares of the stock were exchanged, compared to its average volume of 2,391,894. The business's 50 day moving average is $122.78 and its 200-day moving average is $115.99. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The company has a market capitalization of $30.72 billion, a P/E ratio of 23.72, a P/E/G ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's payout ratio is 37.69%.

Wall Street Analyst Weigh In

CAH has been the topic of a number of recent analyst reports. UBS Group upped their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a research note on Monday, November 4th. Morgan Stanley upped their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research note on Friday, January 10th. Finally, Evercore ISI upgraded shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus target price of $136.87.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.